Showing results (71-80 of 543) with videos related to
Sort By:
Pageof 55
Cleveland Clinic Journal of Medicine|June 19, 2001
C-reactive protein: a 'golden marker' for inflammation and coronary artery diseaseV B Patel, M A Robbins, E J TopolJournal of the American College of Cardiology|April 12, 2000
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery diseaseA M Lincoff, R M Califf, E J TopolCirculation|November 1, 1990
Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trialsR M Califf, L Harrelson-Woodlief, E J TopolLancet (London, England)|January 29, 1999
Platelet GPIIb-IIIa blockersE J Topol, T V Byzova, E F PlowAmerican Heart Journal|August 1, 1991
Combination thrombolytic therapy: a comparison of simultaneous and sequential regimens of tissue plasminogen activator and urokinaseJ A Morris, D W Muller, E J TopolThe American Journal of Medicine|January 1, 1986
Cardiac papillary fibroelastoma and stroke. Echocardiographic diagnosis and guide to excisionE J Topol, R O Biern, B A ReitzAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Oral glycoprotein IIb/IIIa inhibitors: why don't they work?D P Chew, D L Bhatt, E J TopolJournal of the American College of Cardiology|December 1, 1996
Role of platelets in restenosis after percutaneous coronary revascularizationH Le Breton, E F Plow, E J TopolThe American Journal of Cardiology|July 15, 1990
Possible survival benefit from concomitant beta-but not calcium-antagonist therapy during reperfusion for acute myocardial infarctionS G Ellis, D W Muller, E J TopolAnnals of Internal Medicine|May 15, 1991
Coronary angiography after thrombolytic therapy for acute myocardial infarctionE J Topol, D R Holmes, W J RogersPageof 55